![]() The extra room will help accommodate for less invasive surgeries, like laparoscopic surgeries, which require additional equipment.ĭr Carolyn Best explains, “in the old operating rooms, the set-ups were extensive. The new rooms are roughly 20 to 25 per cent larger. Each room cost approximately $1.6 million to build and is part of the larger redevelopment of the centre. Reporting for this story was paid for through The Afghan Journalists in Residence Project funded by Meta.Hamilton Health Sciences unveiled a set of new operating rooms to replace the existing ones at McMaster University Medical Centre.ĭoctors say the 8 new operating rooms are designed for today’s technology and surgical needs. “It would be interesting to see how effective these anti-fatigue medications will be for treating related illnesses such as chronic fatigue syndrome and long COVID, now that we know they work for a similar condition,” added Zeraatkar. Zeraatkar also says solriamfetol can raise blood pressure and it may be risky for people with OSA, as many of them also have cardiovascular issues. While the study determined solriamfetol is “likely the best” anti-fatigue drug for EDS, senior study author and an assistant professor of the Department of Anesthesia Zeraatkar says the drugs armodafinil–modafinil and pitolisant are also effective in combating fatigue. ![]() Improving this situation is of paramount importance to physicians.”Īccording to Pitre, OSA affects nearly one billion people in the world and puts many of them at risk of EDS. “Among those patients, many will have EDS, which affects their quality of life, making them less productive and also puts them at risk of other psychological issues. Many people have symptoms as the condition is highly associated with obesity, which affects a large and increasing number of people in Canada, the United States and other high-income countries,” added Pitre. “Fifteen to 30 per cent of people in North America have a diagnosis of OSA and the prevalence could be much higher as many others are undiagnosed. ![]() Tyler Pitre, study author and resident physician in internal medicine at McMaster University and incoming respirology fellow at the University of Toronto, suggests people with OSA should use their PAP machine first to treat EDS, and if they are still sleepy they can turn to medication for treatment. However, some people with OSA still experience EDS and may benefit from anti-fatigue medication. The standard treatment for OSA is a positive airway pressure (PAP) mask that uses compressed air to support lung airways during sleep. Their research was conducted from October 2022 to January 2023.ĮDS is when someone falls asleep or has a desire for sleep while expected to be awake, and it is often a symptom of sleep-related disorders. Their findings are based on a systematic review of 14 clinical trials of anti-fatigue medications involving 3,085 people, as well as analysing data from MEDLINE, CENTRAL, EMBASE and in a specific network meta-analysis. Researchers from McMaster University have found what they call the “most effective” treatment for people with obstructive sleep apnea (OSA) who suffer from excessive daytime sleepiness (EDS).ĭena Zeraatkar and Tyler Pitre published their results in the peer-reviewed publication Annals of Internal Medicine, claiming the drug solriamfetol is “likely the best medication” for EDS.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |